Dec 16th, 2022 |
14:52
Biosimilars: Managing switch scenarios with biologics and biosimilars
Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Drs. Christina Ha and Frank Scott. Each episode features a challenging patient case and short discussion.
In episode 2 of 4, we’ll discuss:
• How do you prepare your team and the patient for a switch to a biosimilar?
• Are there any situations where switching is not appropriate?
• What do you think about multiple switches?
• How do you minimize the potential for a nocebo effect?
This series is supported by independent medical education grants from Amgen and Pfizer.
To collect CME credit for listening, visit agau.gastro.org.